跳至主要内容
临床试验/NL-OMON22803
NL-OMON22803尚未招募不适用

Prevention of incisional hernia in high-risk patients with prophylactic slowly-resorbable TIGR® Matrix mesh in midline laparotomies.

ovus Scientific AB, Uppsala Sweden0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Elective midline laparotomy for patients with Abdominal Aortic Aneurysm.
  • -Age = 18 years.
  • -Signed informed consent by patient.

排除标准

  • -Pregnancy.
  • -Emergency procedures.
  • -Inclusion in other trials with interference of the primary endpoint.
  • -Life expectancy less than 24 months (as estimated by the attending physician).
  • -Immune suppression therapy within 2 weeks before surgery.

研究者

发起方
ovus Scientific AB, Uppsala Sweden

相似试验

Prevention of incisional hernia in high-risk... | 临床试验